Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol

Abstract Background ‘Clinically important deterioration’ (CID) is a composite endpoint measuring worsening of the key clinical features of chronic obstructive pulmonary disease (COPD), namely lung function, patient-reported outcomes, and exacerbations. ACLIFORM and AUGMENT were two 24-week, randomiz...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Dave Singh, Anthony D. D’Urzo, Ferran Chuecos, Anna Muñoz, Esther Garcia Gil
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2017-05-01
Sarja:Respiratory Research
Aiheet:
COPD
LABA
LAMA
Bronchodilation
Chronic respiratory disease
Linkit:http://link.springer.com/article/10.1186/s12931-017-0583-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia